| Date | Form | Description | Docs | XBRL | Pages |
| 01/19/17 | 8-K | Current report filing |
|
6 | |
| 01/11/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/11/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/10/17 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/03/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
5 | |
| 12/08/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
|
85 |
| 12/07/16 | 8-K | Current report filing |
|
6 | |
| 12/07/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
138 | |
| 11/17/16 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/09/16 | 3 | Initial statement of beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...